About Extrel
Extrel is a Healthcare company based in Pittsburgh (United States) founded in 1964, and was acquired by ABB in January 2004. Quadrupole mass spectrometers and residual gas analyzers are manufactured. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its competitors include 908 Devices, Advion and Impedimed; 3 of its 3 listed competitors have raised funding.
Company details
Extrel was founded in 1964 and is headquartered in Pittsburgh, United States. Operations center on the production of quadrupole mass spectrometers and residual gas analyzers within the scientific instrumentation sector. Products such as the MAX-QMS flange-mounted system, MAX-LT flange-mounted RGA MS, MSMS systems, and Extrel RGA are offered. Gas analysis systems, electronics, custom systems, and OEM equipment and hardware are also developed and provided.
Apps and channels of Extrel
its YouTube channel Process Insights has 115 subscribers and 30 videos.
Videos from Extrel
The most watched videos on Extrel's YouTube channel, Process Insights (115 subscribers). Click a video to play it here.
More on Process Insights.
Investors in Extrel
Extrel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ABB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-utility robotic solutions and automation products are provided to industries. | abb.com | Zurich, Switzerland |
Investor details for Extrel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Extrel
2 dated milestones of Extrel across 40 years, from founding to its latest funding, stage changes and deals.
- Founded Extrel is founded.
- Exit Acquired by ABB.
Competitors of Extrel
Extrel has 3 listed competitors in our database, 3 of them funded. They include 908 Devices, Advion and Impedimed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 908devices.com | 2012 | Boston, United States | $68.22M | 93 | Handheld chemical detection devices are manufactured using mass spectrometry. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. |
Detailed competitors of Extrel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Extrel
Websites that share an audience with Extrel (extrel.com).
Websites whose visitors overlap most with Extrel. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| advion.com | 100% | 8.1K | #2,624,018 | View details | |
ionics.ca | ionics.ca | 94% | – | ||
hems-workshop.org | hems-workshop.org | 94% | #7,375,762 | – | |
i-mass.com | i-mass.com | 94% | – | ||
komiveslab.ucsd.edu | komiveslab.ucsd.edu | 94% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Extrel
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Extrel (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Extrel
Extrel was founded in 1964.
Extrel is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Extrel was founded in 1964 and is headquartered in Pittsburgh, United States. Operations center on the production of quadrupole mass spectrometers and residual gas analyzers within the scientific instrumentation sector. Products such as the MAX-QMS flange-mounted system, MAX-LT flange-mounted RGA MS, MSMS systems, and Extrel RGA are offered. Gas analysis systems, electronics, custom systems, and OEM equipment and hardware are also developed and provided.
Extrel's top competitors include 908 Devices, Impedimed and Advion.
Extrel has 1 investor. Key investors include ABB.
Yes. Extrel was acquired by ABB in January 2004.